Related Experiment Video
Updated: Jun 23, 2026

16:56
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?
C Lombardi1, C Incorvaia, M Braga
1Pneumoallergology Unit, S. Orsola FBF Hospital, Brescia, Italy.
Allergy
|April 28, 2009
Summary
Sublingual immunotherapy (SLIT) administration varies widely, especially for pollen allergies. This review suggests preferred regimens based on clinical evidence for optimal treatment.
Area of Science:
- Allergy and Immunology
- Immunotherapy Research
- Clinical Trial Analysis
Background:
- Sublingual immunotherapy (SLIT) administration protocols, including dosage, build-up, duration, and maintenance frequency, exhibit significant variability.
- Pollen SLIT presents additional complexity with preseasonal, coseasonal, and pre-coseasonal treatment regimens.
- Administration regimens have practical and economic implications for patient care and healthcare systems.
Purpose of the Study:
- To review existing randomized double-blind controlled studies on pollen SLIT.
- To derive evidence-based recommendations for preferred pollen SLIT administration regimens.
- To provide guidance for optimizing SLIT treatment protocols.
Main Methods:
- Systematic literature review of randomized double-blind controlled studies.
- Analysis of studies focusing on pollen sublingual immunotherapy.
- Evaluation of different administration modalities: dosing, build-up, duration, and maintenance frequency.
Main Results:
- Variability in dosing, build-up, duration, and maintenance frequency identified across pollen SLIT studies.
- Preseasonal, coseasonal, and pre-coseasonal regimens show differential efficacy and practical considerations.
- Evidence-based suggestions for preferred administration regimens were derived from the analyzed literature.
Conclusions:
- Standardizing administration regimens for pollen SLIT is crucial for consistent clinical outcomes.
- Experimentally-supported suggestions can guide clinicians in selecting optimal SLIT protocols.
- Further research may refine recommendations for specific pollen allergens and patient populations.
Related Concept Videos
Allergic Reactions
Overview
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

